ARTICLE | Company News
Human Genome Sciences, GlaxoSmithKline deal
February 20, 2006 8:00 AM UTC
HGSI received a $5 million milestone payment from GSK triggered by the pharma company submitting an IND to start Phase I trials of GSK716155 to treat diabetes. GSK licensed exclusive worldwide rights...